Vineeth Varanasi

577 total citations
10 papers, 388 citations indexed

About

Vineeth Varanasi is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Vineeth Varanasi has authored 10 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 2 papers in Dermatology and 2 papers in Rheumatology. Recurrent topics in Vineeth Varanasi's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (2 papers). Vineeth Varanasi is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (2 papers). Vineeth Varanasi collaborates with scholars based in India, United States and Switzerland. Vineeth Varanasi's co-authors include Satyajit Rath, Krishna M. Ella, Marcela F. Pasetti, Viswanathan Mohan, Myron M. Levine, Vineeta Bal, Tushar Vaidya, Anna George, Balachandran Ravindran and Anupriya Khare and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Blood.

In The Last Decade

Vineeth Varanasi

10 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vineeth Varanasi India 6 157 129 114 71 56 10 388
Michaela Nováková Czechia 14 107 0.7× 170 1.3× 83 0.7× 193 2.7× 31 0.6× 35 556
Renée M. Laird United States 14 215 1.4× 108 0.8× 46 0.4× 77 1.1× 103 1.8× 31 522
Mariëtta M Ravesloot-Chávez United States 5 231 1.5× 149 1.2× 53 0.5× 78 1.1× 94 1.7× 5 480
Mark A. Schmetz United States 9 165 1.1× 46 0.4× 67 0.6× 130 1.8× 71 1.3× 11 429
Vishnampettai G. Ramachandran India 15 95 0.6× 112 0.9× 26 0.2× 48 0.7× 74 1.3× 34 431
Martha C. Moreno‐Lafont Mexico 14 279 1.8× 44 0.3× 44 0.4× 34 0.5× 101 1.8× 35 521
Anna Rydström Sweden 12 354 2.3× 131 1.0× 156 1.4× 95 1.3× 30 0.5× 13 636
Pilar Samperio Ventayol Germany 6 100 0.6× 74 0.6× 47 0.4× 47 0.7× 108 1.9× 10 382
Hilo Yen Japan 11 123 0.8× 105 0.8× 62 0.5× 196 2.8× 20 0.4× 14 469
Ryan G. Gaudet Canada 10 233 1.5× 132 1.0× 26 0.2× 54 0.8× 96 1.7× 11 564

Countries citing papers authored by Vineeth Varanasi

Since Specialization
Citations

This map shows the geographic impact of Vineeth Varanasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vineeth Varanasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vineeth Varanasi more than expected).

Fields of papers citing papers by Vineeth Varanasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vineeth Varanasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vineeth Varanasi. The network helps show where Vineeth Varanasi may publish in the future.

Co-authorship network of co-authors of Vineeth Varanasi

This figure shows the co-authorship network connecting the top 25 collaborators of Vineeth Varanasi. A scholar is included among the top collaborators of Vineeth Varanasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vineeth Varanasi. Vineeth Varanasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Takahashi, Hidetoshi, Atsushi Fukunaga, Koremasa Hayama, et al.. (2024). Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria. Allergology International. 74(1). 136–143. 1 indexed citations
2.
Ensina, Luís Felipe, Jonathan A. Bernstein, Gordon Sussman, et al.. (2023). Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: Results from the Phase-3 Pivotal Trials. Journal of Allergy and Clinical Immunology. 151(2). AB130–AB130. 5 indexed citations
3.
Varanasi, Vineeth, Tapas Mukherjee, Ramanamurthy Boppana, et al.. (2017). Mediation of transitional B cell maturation in the absence of functional Bruton’s tyrosine kinase. Scientific Reports. 7(1). 46029–46029. 5 indexed citations
5.
Varanasi, Vineeth, Aly A. Khan, & Alexander V. Chervonsky. (2014). Loss of the death receptor CD95 (Fas) expression by dendritic cells protects from a chronic viral infection. Proceedings of the National Academy of Sciences. 111(23). 8559–8564. 8 indexed citations
6.
Zloza, Andrew, Frederick J. Kohlhapp, Gretchen E. Lyons, et al.. (2012). NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses. Nature Medicine. 18(3). 422–428. 49 indexed citations
7.
Varanasi, Vineeth, Lia Avanesyan, Desirée Schumann, & Alexander V. Chervonsky. (2012). Cytotoxic Mechanisms Employed by Mouse T Cells to Destroy Pancreatic β-Cells. Diabetes. 61(11). 2862–2870. 30 indexed citations
8.
Varanasi, Vineeth, Hamid Mattoo, Abhishek Das, et al.. (2010). A Superantigen Interacts with Leishmanial Infection in Antigen‐Presenting Cells to Regulate Cytokine Commitment of Responding CD4 T Cells. The Journal of Infectious Diseases. 202(8). 1234–1245. 2 indexed citations
9.
Varanasi, Vineeth, et al.. (2008). Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen. Diagnostic Microbiology and Infectious Disease. 61(1). 23–30. 49 indexed citations
10.
Khare, Anupriya, Vineeth Varanasi, Asok Mukhopadhyay, et al.. (2004). Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood. 104(4). 1191–1197. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026